SG11202108821XA - Sghrt polypeptide and related products, methods and uses - Google Patents

Sghrt polypeptide and related products, methods and uses

Info

Publication number
SG11202108821XA
SG11202108821XA SG11202108821XA SG11202108821XA SG11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA
Authority
SG
Singapore
Prior art keywords
sghrt
polypeptide
methods
related products
products
Prior art date
Application number
SG11202108821XA
Other languages
English (en)
Inventor
Roger Sik Yin Foo
Dang Vinh Do
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11202108821XA publication Critical patent/SG11202108821XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11202108821XA 2019-02-12 2020-02-12 Sghrt polypeptide and related products, methods and uses SG11202108821XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201901195V 2019-02-12
PCT/SG2020/050069 WO2020167252A1 (en) 2019-02-12 2020-02-12 Sghrt polypeptide and related products, methods and uses

Publications (1)

Publication Number Publication Date
SG11202108821XA true SG11202108821XA (en) 2021-09-29

Family

ID=72045672

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108821XA SG11202108821XA (en) 2019-02-12 2020-02-12 Sghrt polypeptide and related products, methods and uses

Country Status (5)

Country Link
US (1) US20220227822A1 (de)
EP (1) EP3924366A4 (de)
CN (1) CN113966341B (de)
SG (1) SG11202108821XA (de)
WO (1) WO2020167252A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030176681A1 (en) * 1997-10-24 2003-09-18 Ping Feng 148 human secreted proteins
EP3554512A4 (de) * 2016-12-14 2020-07-15 Agency For Science, Technology And Research Verfahren zur regelung der funktion einer herzzelle, zugehörige nukleotide und verbindungen

Also Published As

Publication number Publication date
CN113966341A (zh) 2022-01-21
CN113966341B (zh) 2024-09-17
WO2020167252A1 (en) 2020-08-20
EP3924366A4 (de) 2023-01-04
EP3924366A1 (de) 2021-12-22
US20220227822A1 (en) 2022-07-21

Similar Documents

Publication Publication Date Title
RS65903B1 (sr) Polipeptid, postupak za njegovu proizvodnju i njegova upotreba
EP3674312A4 (de) Neuartiges polypeptid und verfahren zur herstellung von imp unter verwendung davon
IL291299A (en) Anti-TNFR2 antibodies, preparations containing them and their uses
IL282178A (en) Products, uses and methods
EP3680331A4 (de) Modifiziertes cas9-protein und verwendung davon
IL287781A (en) Clec-12a binding polypeptides and uses thereof
ZA202103259B (en) Modified cas9 protein, and use thereof
GB201905674D0 (en) Aquafaba products and methods
GB2591554B (en) Composiitons and methods and uses relating thereto
IL287782A (en) 33cd-binding polypeptides and their uses
GB201813648D0 (en) Methods, products & uses relating thereto
EP3634145A4 (de) Polypeptid, verwendung und verfahren zur proteinhydrolyse
GB2577981B (en) Methods, products & Uses relating thereto
EP3341004A4 (de) Mrka-polypeptide, antikörper und verwendungen davon
IL268971A (en) A polypeptide, a segment of a polypeptide, its derivation and their applications
EP3569613A4 (de) Peptid aus erythropoietin, herstellungsverfahren dafür und verwendung davon
GB201802184D0 (en) Products and methods
IL287386A (en) Promoter sequence and related products and their use
EP3611181A4 (de) Auf atp1a1t abzielendes polypeptid und dessen verwendung
EP3973550C0 (de) Peptidionogel, zusammensetzung, verfahren und verwendungen davon
ZA202005050B (en) Polypeptide, compositions and uses thereof
GB2583732B (en) Methods and products
SG11202108821XA (en) Sghrt polypeptide and related products, methods and uses
GB201912021D0 (en) Methods, products & Uses relating thereto
EP3562839A4 (de) Rekombinante polypeptide, zusammensetzungen und verfahren dafür